Mhlongo NN - Search Results

1

Tailored-pharmacophore model to enhance virtual screening and drug discovery: a case study on the identification of potential inhibitors against drug-resistant Mycobacterium tuberculosis (3R)-hydroxyacyl-ACP dehydratases.

Machaba KE, Mhlongo NN, Dokurugu YM, Soliman ME. Machaba KE, et al. Among authors: mhlongo nn. Future Med Chem. 2017 Jun;9(10):1055-1071. doi: 10.4155/fmc-2017-0020. Epub 2017 Jun 20. Future Med Chem. 2017. PMID: 28632406

2

Anti-cancer glycosidase inhibitors from natural products: a computational and molecular modelling perspective.

Singh A, Mhlongo N, Soliman ME. Singh A, et al. Anticancer Agents Med Chem. 2015;15(8):933-46. doi: 10.2174/1871520615666150223123622. Anticancer Agents Med Chem. 2015. PMID: 25706917 Review.

3

Metal complexes in cancer therapy - an update from drug design perspective.

Ndagi U, Mhlongo N, Soliman ME. Ndagi U, et al. Drug Des Devel Ther. 2017 Mar 3;11:599-616. doi: 10.2147/DDDT.S119488. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28424538 Free PMC article. Review.

4

In Silico Drug Repurposing Approach: Investigation of Mycobacterium tuberculosis FadD32 Targeted by FDA-Approved Drugs.

Ngidi NTP, Machaba KE, Mhlongo NN. Ngidi NTP, et al. Among authors: mhlongo nn. Molecules. 2022 Jan 20;27(3):668. doi: 10.3390/molecules27030668. Molecules. 2022. PMID: 35163931 Free PMC article.

5

Sliding Clamp of DNA Polymerase III as a Drug Target for TB Therapy: Comprehensive Conformational and Binding Analysis from Molecular Dynamic Simulations.

Machaba KE, Cele FN, Mhlongo NN, Soliman ME. Machaba KE, et al. Among authors: mhlongo nn. Cell Biochem Biophys. 2016 Dec;74(4):473-481. doi: 10.1007/s12013-016-0764-3. Cell Biochem Biophys. 2016. PMID: 27651172

6

Induced Mutation Proves a Potential Target for TB Therapy: A Molecular Dynamics Study on LprG.

Machaba KE, Mhlongo NN, Soliman MES. Machaba KE, et al. Among authors: mhlongo nn. Cell Biochem Biophys. 2018 Sep;76(3):345-356. doi: 10.1007/s12013-018-0852-7. Epub 2018 Aug 2. Cell Biochem Biophys. 2018. PMID: 30073572

7

Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase-a molecular modelling perspective.

Tembe N, Machaba KE, Ndagi U, Kumalo HM, Mhlongo NN. Tembe N, et al. Among authors: mhlongo nn. J Mol Model. 2022 Jan 13;28(2):35. doi: 10.1007/s00894-021-04993-w. J Mol Model. 2022. PMID: 35022913

8

Emergence of a Promising Lead Compound in the Treatment of Triple Negative Breast Cancer: An Insight into Conformational Features and Ligand Binding Landscape of c-Src Protein with UM-164.

Ndagi U, Mhlongo NN, Soliman ME. Ndagi U, et al. Among authors: mhlongo nn. Appl Biochem Biotechnol. 2018 Jul;185(3):655-675. doi: 10.1007/s12010-017-2677-z. Epub 2017 Dec 27. Appl Biochem Biotechnol. 2018. PMID: 29282631

9

Re-emergence of an orphan therapeutic target for the treatment of resistant prostate cancer - a thorough conformational and binding analysis for ROR-γ protein.

Ndagi U, Mhlongo NN, Soliman ME. Ndagi U, et al. Among authors: mhlongo nn. J Biomol Struct Dyn. 2018 Feb;36(2):335-350. doi: 10.1080/07391102.2016.1277555. Epub 2017 Jan 16. J Biomol Struct Dyn. 2018. PMID: 28027708

10

The impact of Thr91 mutation on c-Src resistance to UM-164: molecular dynamics study revealed a new opportunity for drug design.

Ndagi U, Mhlongo NN, Soliman ME. Ndagi U, et al. Among authors: mhlongo nn. Mol Biosyst. 2017 May 30;13(6):1157-1171. doi: 10.1039/c6mb00848h. Mol Biosyst. 2017. PMID: 28463369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters